Koers Port Erin Biopharma Investments Ltd London S.E.
Aandelen
IM00B6QH1J21
Beleggingsbeheer & Fondsbeheerders
Omzet 2022 | 6,42 mln. 8,17 mln. 7,59 mln. | Omzet 2023 | 29,7 mln. 37,79 mln. 35,1 mln. | Marktkapitalisatie | 104 mln. 132 mln. 122 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 8 mln. 10,18 mln. 9,45 mln. | Nettowinst (verlies) 2023 | 22 mln. 27,99 mln. 26 mln. | EV/omzet 2022 | 1,58 x |
Nettoliquiditeiten 2022 | 146 mln. 186 mln. 173 mln. | Nettoliquiditeiten 2023 | 170 mln. 216 mln. 201 mln. | EV/omzet 2023 | -2,23 x |
K/w-verhouding 2022 |
17,6
x | K/w-verhouding 2023 |
4,73
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 83,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 30-05-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 03-05-11 |
Richard Reed
BRD | Director/Board Member | 51 | 31-05-19 |
David Giampaolo
BRD | Director/Board Member | 65 | 31-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,72% | 3,16 mld. | |
+12,50% | 1,76 mld. | |
+13,91% | 1,6 mld. | |
-11,54% | 1,21 mld. | |
+20,86% | 813 mln. | |
+6,81% | 647 mln. | |
+38,07% | 597 mln. | |
+44,88% | 527 mln. | |
-4,17% | 506 mln. |